Rare disease nomenclature and coding: challenges, systems, and policies in the global context
Authors:
Open Access
- 11 June 2026
- journal article
- review article
- Published by Elsevier in Archives of Medical Research
- Vol. 57 (8) , 103466
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational studyThe Lancet Digital Health, 2025
- Global insight into rare disease and orphan drug definitions: a systematic literature reviewBMJ Open, 2025
- Building a National Policy for Rare Disease in BrazilJournal of Community Genetics, 2024
- ICD-10 - ORPHA: An Interactive Complex Network Model for Brazilian Rare DiseasesProcedia Computer Science, 2024
- The National Hospital Care Survey Is a Unique Source of Data on Rare DiseasesValue in Health, 2022
- Can you hear us now? The impact of health-care utilization by rare disease patients in the United StatesGenetics in Medicine, 2021
- Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet databaseEuropean Journal of Human Genetics, 2019
- The collective impact of rare diseases in Western Australia: an estimate using a population-based cohortGenetics in Medicine, 2017
- Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupValue in Health, 2015
- A New Coding System for Metabolic Disorders Demonstrates Gaps in the International Disease Classifications ICD-10 and SNOMED-CT, Which Can Be Barriers to Genotype-Phenotype Data SharingHuman Mutation, 2013